Access SARS-CoV-2 IgM Antibody Test
By integrating a high-quality set of SARS-CoV-2-specific antibody tests into their routine workflow, laboratories of all sizes can give physicians greater clarity on patient immune response to the virus that causes COVID-19.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Very cool kit, but you need more if you want to do a deeper investigation.
Diagnosis
They are very specific and very sensitive, the problem is that because of their nature you have to integrate them with a more specific technique such as PCR in order to see if positivity is due to the fact that virus is still present or not.
Review Date: 15 Jun 2021 | Beckman Coulter Clinical Diagnostics
Good sensitivity and specificity.
Immunology
For epidemiology evaluation.
Review Date: 6 Jun 2021 | Beckman Coulter Clinical Diagnostics
Great assay.
Coronavirus assay
Access SARS-CoV-2 IgM assay played a big role of identifying patients with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection by corona. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity, so it was a very effective assay with coronavirus patients in our region.
Review Date: 25 May 2021 | Beckman Coulter Clinical Diagnostics
Tests are reliable and repeated. Very good quality.
Cancer research
The Access SARS-CoV2 IgM product by Beckman Coulter was very well received by customers. The value for money rating is very good. Tests are reliable and repeated. No reservations as to the quality and ease of performing the test.
Review Date: 25 May 2021 | Beckman Coulter Clinical Diagnostics
The Case for Separate Tests
When a total IgG and IgM assay is positive, it is unclear if the patient is currently infected or has an immune response to a prior infection.
This is because developed IgM is not sustained, while developed IgG can potentially be sustained longer, depending upon the infection and the individual.
In various studies, it has been seen that seroconversion for SARS-CoV-2 IgG and IgM may occur simultaneously or sequentially1. Thus, it’s important to identify both IgG and IgM individually. An IgM assay may provide information about current or recent infection; while IgG may signal a more sustained immune response.
A Menu that Matters
By integrating high-quality antibody tests into a routine workflow, laboratories of all sizes can offer physicians a set of tools to gain greater clarity on individuals who have antibodies to SARS-CoV-2 due to prior or recent viral infection.
High Sensitivity and Specificity
High sensitivity and specificity are key to providing physicians an accurate picture of patient immune response. Both the Access SARS-CoV-2 IgM and Access SARS-CoV-2 IgG tests have been validated against large, broad-based samples to ensure high quality.
Seamless Integration with Routine Lab Workflow
The Access SARS-CoV-2 IgM assay can be seamlessly integrated into current laboratory workflow without the need for batching or special maintenance. This can help your laboratory experience industry-leading system uptime.
